MAG Participates in Blackburn Dubai Property Expo, Highlights Premium Development to British Buyers
12.2.2025 15:51:00 CET | Business Wire | Press release
MAG, one of the UAE’s leading real estate developers, is set to participate in the Blackburn Dubai Property Expo, taking place on 22-23 February at Stanley House Hotel & Spa, UK. The developer will showcase its flagship project, The Ritz-Carlton Residences, Dubai, Creekside, part of the Keturah Resort, presenting a unique opportunity for an unparalleled lifestyle with unmatched service and amenities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250212516764/en/
The Ritz-Carlton Residences, Dubai, Creekside at the Keturah Resort (Photo: AETOSWire)
Dubai's real estate sector continues to see strong growth, driven by HNWIs seeking luxury developments. With nearly 740 branded residences globally and that figure expected to double by 2031, Dubai is a key player, with 140 projects in the pipeline. In H1 2024, branded residences made up 7.2% of all property transactions, generating $7.8 billion—12.6% of last year’s total transaction value. These properties offer premium pricing and strong rental yields, making them an attractive investment option.
Located within Keturah Resort, the first fully wellness-certified resort in the MENA region, The Ritz-Carlton Residences, Dubai, Creekside, comprises 200 residences across seven buildings and 12 mansions, each featuring exclusive yacht berthing for residents. Homeowners will benefit from an impressive range of world-class facilities, including a wellness center, a Clubhouse complete with a private members-only club, a ladies’ club, a kids’ club, fine dining and Michelin-star restaurants, a 550-metre promenade, sustainable and organic-focused retail spaces, 24/7 private parking with valet, and a gated community with unique views of the wildlife sanctuary, Burj Khalifa, Dubai Creek Harbor, and Meydan.
David James, Director of Sales at MAG, said: "The UAE’s real estate sector remains strong, with sustained interest from international investors, particularly from the UK. By showcasing Keturah Resort at the Blackburn Dubai Property Expo, we have the opportunity to highlight its unique features and present a premium opportunity set to reshape the real estate landscape in the MENA region."
The project is located on Dubai Creek, providing convenient access to Dubai Downtown, Dubai International Financial Centre, and Dubai International Airport.
For more information, please visit www.theresidencescreeksidedubai.com
Legal Disclaimer
The Ritz-Carlton Residences, Dubai, Creekside, are not owned, developed, or sold by The Ritz-Carlton Hotel Company, LLC or its affiliates (“Ritz-Carlton”). MAG of Life FZ-LLC uses The Ritz-Carlton marks under a license from Ritz-Carlton, which has not confirmed the accuracy of any of the statements or representations made herein.
Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250212516764/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release
Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release
Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 15:26:00 CEST | Press release
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom